bluebird bio (BLUE) PT Lowered to $14 at BofA Securities
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry lowered the price target on bluebird bio (NASDAQ: BLUE) to $14.00 (from $22.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Brother Industries Ltd (6448:JP) to Neutral
- argenx SE (ARGX) PT Raised to $1,150 at Wedbush
- Daiseki Co Ltd (9793:JP) PT Lowered to JPY5,100 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
